Target-Based Drug Discovery: the Emerging Success of Frontal Affinity Chromatography Coupled to Mass Spectrometry

被引：33
|
作者：
Calleri, Enrica [1 ]
Temporini, Caterina [1 ]
Caccialanza, Gabriele [1 ]
Massolini, Gabriella [1 ]
机构：
[1] Univ Pavia, Dipartimento Chim Farmaceut, I-27100 Pavia, Italy
来源：
CHEMMEDCHEM | 2009年 / 4卷 / 06期
关键词：
drug discovery; high-throughput screening; binding assays; mass spectrometry; FAC-MS; IMMOBILIZED P-GLYCOPROTEIN; RECEPTOR STATIONARY-PHASE; SMALL-MOLECULE INHIBITORS; TYROSINE KINASE RECEPTOR; LIQUID-CHROMATOGRAPHY; MS DETECTION; SCREENING TECHNIQUES; BINDING AFFINITIES; LEAD GENERATION; FAC-MS;
D O I：
10.1002/cmdc.200800436
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：905 / 916
页数：12
相关论文
共 50 条
  • [31] Enrichment and analysis of nonenzymatically glycated peptides: Boronate affinity chromatography coupled with electron-transfer dissociation mass spectrometry
    Zhang, Qibin
    Tang, Ning
    Brock, Jonathan W. C.
    Mottaz, Heather M.
    Ames, Jennifer M.
    Baynes, John W.
    Smith, Richard D.
    Metz, Thomas O.
    JOURNAL OF PROTEOME RESEARCH, 2007, 6 (06) : 2323 - 2330
  • [32] Monolithic membrane-receptor columns: Optimization of column performance for frontal affinity chromatography/mass spectrometry applications
    Besanger, TR
    Hodgson, RJ
    Guillon, D
    Brennan, JD
    ANALYTICA CHIMICA ACTA, 2006, 561 (1-2) : 107 - 118
  • [33] Impact of Mass Spectrometry-Based Technologies and Strategies on Chemoproteomics as a Tool for Drug Discovery
    McClure, Ryan A.
    Williams, Jon D.
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (08): : 785 - 791
  • [34] Target-Based Small Molecule Drug Discovery for Colorectal Cancer: A Review of Molecular Pathways and In Silico Studies
    Moshawih, Said
    Lim, Ai Fern
    Ardianto, Chrismawan
    Goh, Khang Wen
    Kifli, Nurolaini
    Goh, Hui Poh
    Jarrar, Qais
    Ming, Long Chiau
    BIOMOLECULES, 2022, 12 (07)
  • [35] Target-based vs. phenotypic screenings in Leishmania drug discovery: A marriage of convenience or a dialogue of the deaf?
    Reguera, Rosa M.
    Calvo-Alvarez, Estefania
    Alvarez-Velilla, Raquel
    Balana-Fouce, Rafael
    INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2014, 4 (03): : 355 - 357
  • [36] Liquid chromatography/mass spectrometry (LC/MS)-based glycoproteomics technologies for cancer biomarker discovery
    Kaji H.
    Isobe T.
    Clinical Proteomics, 2008, 4 (1-2) : 14 - 24
  • [37] Editorial: Mass spectrometry-based proteomics in drug discovery and development
    Pejchinovski, Martin
    Magalhaes, Pedro
    Metzger, Jochen
    FRONTIERS IN MEDICINE, 2024, 11
  • [38] Drug Target Identification Using Affinity Core-Shell Magnetic Nanoparticles and Mass Spectrometry
    Wei, Yunhuan
    Wang, Tongdan
    Liu, Chao
    Zhang, Qianqian
    Wang, Lishun
    Tang, Gongli
    Kang, Jingwu
    CHINESE JOURNAL OF CHEMISTRY, 2013, 31 (06) : 715 - 720
  • [39] Profiling the Protein Targets of Unmodified Bio-Active Molecules with Drug Affinity Responsive Target Stability and Liquid Chromatography/Tandem Mass Spectrometry
    Hwang, Hui-Yun
    Kim, Tae Young
    Szasz, Marcell A.
    Dome, Balazs
    Malm, Johan
    Marko-Varga, Gyorgy
    Kwon, Ho Jeong
    PROTEOMICS, 2020, 20 (09)
  • [40] COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery
    Kumar, Sunny
    Basu, Malini
    Ghosh, Pratyasha
    Pal, Uttam
    Ghosh, Mrinal K.
    GENES & DISEASES, 2023, 10 (04) : 1402 - 1428
12345